MedPath

Introduction and effects of structured drug counselling in the hospital.

Completed
Conditions
cancer, lung diseases
Registration Number
NL-OMON21168
Lead Sponsor
VUmc/NIVE
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
240
Inclusion Criteria

1. Admission at one of the participating departments;

2. Informed consent;

Exclusion Criteria

1. Patients younger than 18 years;

2. Patients who are emotionally or physically not capable to participate;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Difference in knowledge about prescribed medicines between intervention and control group at measurement II, per patient corrected for the basis at measurement I<br>(method: questionnaires);<br /><br>2. Differences in correct use of medicines between intervention and control group at measurement III<br>(method: questionnaires).
Secondary Outcome Measures
NameTimeMethod
1. Differences in spotting and reporting medication deviations during the distribution of medicines in hospital between intervention and control group (measurement II);<br /><br>2. Differences in satisfaction about the received information about medicines (measurement II).
© Copyright 2025. All Rights Reserved by MedPath